TY - JOUR
T1 - Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in Patients with Diabetic Macular Edema
AU - Fang, Mengyuan
AU - Fan, Wenying
AU - Shi, Yue
AU - Ip, Michael S.
AU - Wykoff, Charles C.
AU - Wang, Kang
AU - Falavarjani, Khalil Ghasemi
AU - Brown, David M.
AU - van Hemert, Jano
AU - Sadda, Srini Vas R.
N1 - Funding Information:
All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. Funding/Support: The authors indicate no financial support. Financial Disclosures: Michael S. Ip has been a consultant for Thrombogenics, Omeros, Boehringer Ingelheim, Genentech, Quark, Astellas Institute for Regenerative Medicine, and Allergan. Charles C. Wykoff has been a consultant for or received financial support from Alcon Laboratories, Alimera Sciences, Allergan, Apellis Pharmaceutical, Bayer AG, Clearside Biomedical, D.O.R.C. International, Genentech, Navartis International AG, ONL Therapeutics, Regeneron Pharmaceuticals, REGENXBIO, Roche, Santen, Adverum Biotechnologies, Aerpio Therapeutics, Clearside Biomedical, Ophthotech Corporation, and Taiwan Liposome Company. David M. Brown has been a consultant for or received financial support from Genentech/Roche, Alcon/Novartis, Allergan, Clearside Biomedical, Optos/Nikon, Heidelberg Engineering, Aerpio, Allegra, Regeneron/Bayer, and Genentech. SriniVas R. Sadda has been a consultant for or received financial support from Genentech/Roche, Allergan, Amgen, Oxurion, Heidelberg, Optos, Centervue, Carl Zeiss Meditec, Novartis, Topcon, and Nidek. The following authors have no financial disclosures: Jano van Hemert, Mengyuan Fang, Wenying Fan, Yue Shi, Kang Wang, and Khalil Ghasemi Falavarjani. All authors attest that they meet the current ICMJE criteria for authorship.
Funding Information:
All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. Funding/Support: The authors indicate no financial support. Financial Disclosures: Michael S. Ip has been a consultant for Thrombogenics, Omeros, Boehringer Ingelheim, Genentech, Quark, Astellas Institute for Regenerative Medicine, and Allergan. Charles C. Wykoff has been a consultant for or received financial support from Alcon Laboratories, Alimera Sciences , Allergan , Apellis Pharmaceutical , Bayer AG , Clearside Biomedical , D.O.R.C. International, Genentech , Navartis International AG , ONL Therapeutics , Regeneron Pharmaceuticals , REGENXBIO , Roche , Santen , Adverum Biotechnologies , Aerpio Therapeutics , Clearside Biomedical , Ophthotech Corporation , and Taiwan Liposome Company . David M. Brown has been a consultant for or received financial support from Genentech / Roche , Alcon / Novartis , Allergan , Clearside Biomedical , Optos /Nikon, Heidelberg Engineering , Aerpio , Allegra , Regeneron / Bayer , and Genentech . SriniVas R. Sadda has been a consultant for or received financial support from Genentech / Roche , Allergan , Amgen , Oxurion, Heidelberg , Optos , Centervue , Carl Zeiss Meditec , Novartis , Topcon , and Nidek . The following authors have no financial disclosures: Jano van Hemert, Mengyuan Fang, Wenying Fan, Yue Shi, Kang Wang, and Khalil Ghasemi Falavarjani. All authors attest that they meet the current ICMJE criteria for authorship.
Publisher Copyright:
© 2019 Elsevier Inc.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/10
Y1 - 2019/10
N2 - Purpose: To classify retinal nonperfusion regions (NPRs) in patients with diabetic macular edema (DME) and assess the relationship with severity of DME. Design: Prospective, observational case series. Methods: Forty eyes of 29 patients with treatment-naïve center-involved macular edema secondary to diabetes mellitus were included (The DAVE study, NCT01552408) in this analysis. Ultra-widefield fluorescein angiography (UWF FA) images were transmitted to the Doheny Image Reading Center, where they were corrected using stereographic projection to adjust for peripheral distortion. Two independent, certified graders manually evaluated the NPR and classified the nonperfusion as being associated with leakage or without leakage. The size of these 2 subtypes of NPR were computed in mm2 and assessed across the entire retina and within 3 concentric retinal zones. The relationship between subtype of NPR and the severity of DME was assessed. Results: In 40 eyes with treatment-naïve DME, visual acuity was significantly correlated with central macular thickness (CMT) and macular volume (MV). The NPR with leakage was positively correlated with CMT (R = 0.408, P =.009) and MV (R = 0.399, P =.011), whereas the NPR without leakage was negatively correlated with CMT (R = −0.468, P =.002) and MV (R = −0.473, P =.002). The NPR with leakage in the posterior region was significantly greater compared to the mid-periphery and the far periphery (P <.001), whereas the NPR without leakage was significantly greater in the mid-periphery compared with the far periphery or the posterior region (P =.001). Conclusion: In patients with DME, the severity of DME appears to be positively correlated with NPR with leakage but negatively correlated with NPR without leakage. These findings may have implications for the pathophysiology of DME and the design of protocols for targeted laser in these eyes.
AB - Purpose: To classify retinal nonperfusion regions (NPRs) in patients with diabetic macular edema (DME) and assess the relationship with severity of DME. Design: Prospective, observational case series. Methods: Forty eyes of 29 patients with treatment-naïve center-involved macular edema secondary to diabetes mellitus were included (The DAVE study, NCT01552408) in this analysis. Ultra-widefield fluorescein angiography (UWF FA) images were transmitted to the Doheny Image Reading Center, where they were corrected using stereographic projection to adjust for peripheral distortion. Two independent, certified graders manually evaluated the NPR and classified the nonperfusion as being associated with leakage or without leakage. The size of these 2 subtypes of NPR were computed in mm2 and assessed across the entire retina and within 3 concentric retinal zones. The relationship between subtype of NPR and the severity of DME was assessed. Results: In 40 eyes with treatment-naïve DME, visual acuity was significantly correlated with central macular thickness (CMT) and macular volume (MV). The NPR with leakage was positively correlated with CMT (R = 0.408, P =.009) and MV (R = 0.399, P =.011), whereas the NPR without leakage was negatively correlated with CMT (R = −0.468, P =.002) and MV (R = −0.473, P =.002). The NPR with leakage in the posterior region was significantly greater compared to the mid-periphery and the far periphery (P <.001), whereas the NPR without leakage was significantly greater in the mid-periphery compared with the far periphery or the posterior region (P =.001). Conclusion: In patients with DME, the severity of DME appears to be positively correlated with NPR with leakage but negatively correlated with NPR without leakage. These findings may have implications for the pathophysiology of DME and the design of protocols for targeted laser in these eyes.
UR - http://www.scopus.com/inward/record.url?scp=85068859379&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068859379&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2019.03.030
DO - 10.1016/j.ajo.2019.03.030
M3 - Article
C2 - 30959003
AN - SCOPUS:85068859379
SN - 0002-9394
VL - 206
SP - 74
EP - 81
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
ER -